▶ 調査レポート

世界のアレクチニブ市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Alectinib Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のアレクチニブ市場 2021:企業別、地域別、種類・用途別 / Global Alectinib Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-105X00689資料のイメージです。• レポートコード:GIR-105X00689
• 出版社/出版日:GlobalInfoResearch / 2021年5月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:Pharma & Healthcare
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、アレクチニブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アレクチニブの種類別市場規模(150mg*140カプセル、150mg*28カプセル、20mg*1カプセル、40mg*1カプセル、150mg*26カプセル)、用途別市場規模(切除不能NSCLC、高度NSCLC、再発NSCLC、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・アレクチニブの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Roche、Everest Pharmaceuticals
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:150mg*140カプセル、150mg*28カプセル、20mg*1カプセル、40mg*1カプセル、150mg*26カプセル
・用途別分析2016年-2026年:切除不能NSCLC、高度NSCLC、再発NSCLC、その他
・アレクチニブの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・アレクチニブのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・アレクチニブのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・アレクチニブの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・アレクチニブの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Alectinib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Alectinib size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Alectinib market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Alectinib market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
150mg*140 Capsules
150mg*28 Capsules
20mg*1 Capsule
40mg*1 Capsule
150mg*26 Capsules

Market segment by Application can be divided into
Unresectable NSCLC
Advanced NSCLC
Recurrent NSCLC
Other

The key market players for global Alectinib market are listed below:
Roche
Everest Pharmaceuticals

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Alectinib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Alectinib Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 150mg*140 Capsules
1.2.3 150mg*28 Capsules
1.2.4 20mg*1 Capsule
1.2.5 40mg*1 Capsule
1.2.6 150mg*26 Capsules
1.3 Market Analysis by Application
1.3.1 Overview: Global Alectinib Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Unresectable NSCLC
1.3.3 Advanced NSCLC
1.3.4 Recurrent NSCLC
1.3.5 Other
1.4 Global Alectinib Market Size & Forecast
1.4.1 Global Alectinib Sales in Value (2016-2026))
1.4.2 Global Alectinib Sales in Volume (2016-2026)
1.4.3 Global Alectinib Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Alectinib Production Capacity Analysis
1.5.1 Global Alectinib Total Production Capacity (2016-2026)
1.5.2 Global Alectinib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Alectinib Market Drivers
1.6.2 Alectinib Market Restraints
1.6.3 Alectinib Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Alectinib Product and Services
2.1.4 Roche Alectinib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Everest Pharmaceuticals
2.2.1 Everest Pharmaceuticals Details
2.2.2 Everest Pharmaceuticals Major Business
2.2.3 Everest Pharmaceuticals Alectinib Product and Services
2.2.4 Everest Pharmaceuticals Alectinib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Alectinib Sales by Manufacturer
3.1 Global Alectinib Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Alectinib Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Alectinib
3.4 Market Concentration Rate
3.4.1 Top 3 Alectinib Manufacturer Market Share
3.4.2 Top 6 Alectinib Manufacturer Market Share
3.5 Global Alectinib Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Alectinib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Alectinib Market Size by Region
4.1.1 Global Alectinib Sales in Volume by Region (2016-2026)
4.1.2 Global Alectinib Revenue by Region (2016-2026)
4.2 North America Alectinib Revenue (2016-2026)
4.3 Europe Alectinib Revenue (2016-2026)
4.4 Asia-Pacific Alectinib Revenue (2016-2026)
4.5 South America Alectinib Revenue (2016-2026)
4.6 Middle East and Africa Alectinib Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Alectinib Sales in Volume by Type (2016-2026)
5.2 Global Alectinib Revenue by Type (2016-2026)
5.3 Global Alectinib Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Alectinib Sales in Volume by Application (2016-2026)
6.2 Global Alectinib Revenue by Application (2016-2026)
6.3 Global Alectinib Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Alectinib Sales by Type (2016-2026)
7.2 North America Alectinib Sales by Application (2016-2026)
7.3 North America Alectinib Market Size by Country
7.3.1 North America Alectinib Sales in Volume by Country (2016-2026)
7.3.2 North America Alectinib Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Alectinib Sales by Type (2016-2026)
8.2 Europe Alectinib Sales by Application (2016-2026)
8.3 Europe Alectinib Market Size by Country
8.3.1 Europe Alectinib Sales in Volume by Country (2016-2026)
8.3.2 Europe Alectinib Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Alectinib Sales by Type (2016-2026)
9.2 Asia-Pacific Alectinib Sales by Application (2016-2026)
9.3 Asia-Pacific Alectinib Market Size by Region
9.3.1 Asia-Pacific Alectinib Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Alectinib Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Alectinib Sales by Type (2016-2026)
10.2 South America Alectinib Sales by Application (2016-2026)
10.3 South America Alectinib Market Size by Country
10.3.1 South America Alectinib Sales in Volume by Country (2016-2026)
10.3.2 South America Alectinib Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Alectinib Sales by Type (2016-2026)
11.2 Middle East & Africa Alectinib Sales by Application (2016-2026)
11.3 Middle East & Africa Alectinib Market Size by Country
11.3.1 Middle East & Africa Alectinib Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Alectinib Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Alectinib Typical Distributors
12.3 Alectinib Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Alectinib Revenue by Type, (USD Million), 2021-2026
Table 2. Global Alectinib Revenue by Application, (USD Million), 2021-2026
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Alectinib Product and Services
Table 6. Roche Alectinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Everest Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Everest Pharmaceuticals Major Business
Table 9. Everest Pharmaceuticals Alectinib Product and Services
Table 10. Everest Pharmaceuticals Alectinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Global Alectinib Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 12. Global Alectinib Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 13. Market Position of Manufacturers in Alectinib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 14. Global Alectinib Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 15. Head Office and Alectinib Production Site of Key Manufacturer
Table 16. Global Alectinib Sales by Region (2016-2021e) & (K Pcs)
Table 17. Global Alectinib Sales by Region (2021-2026) & (K Pcs)
Table 18. Global Alectinib Revenue by Region (2016-2021e) & (USD Million)
Table 19. Global Alectinib Revenue by Region (2021-2026) & (USD Million)
Table 20. Global Alectinib Sales by Type (2016-2021e) & (K Pcs)
Table 21. Global Alectinib Sales by Type (2021-2026) & (K Pcs)
Table 22. Global Alectinib Revenue by Type (2016-2021e) & (USD Million)
Table 23. Global Alectinib Revenue by Type (2021-2026) & (USD Million)
Table 24. Global Alectinib Price by Type (2016-2021e) & (USD/Pcs)
Table 25. Global Alectinib Price by Type (2021-2026) & (USD/Pcs)
Table 26. Global Alectinib Sales by Application (2016-2021e) & (K Pcs)
Table 27. Global Alectinib Sales by Application (2021-2026) & (K Pcs)
Table 28. Global Alectinib Revenue by Application (2016-2021e) & (USD Million)
Table 29. Global Alectinib Revenue by Application (2021-2026) & (USD Million)
Table 30. Global Alectinib Price by Application (2016-2021e) & (USD/Pcs)
Table 31. Global Alectinib Price by Application (2021-2026) & (USD/Pcs)
Table 32. North America Alectinib Sales by Country (2016-2021e) & (K Pcs)
Table 33. North America Alectinib Sales by Country (2021-2026) & (K Pcs)
Table 34. North America Alectinib Revenue by Country (2016-2021e) & (USD Million)
Table 35. North America Alectinib Revenue by Country (2021-2026) & (USD Million)
Table 36. North America Alectinib Sales by Type (2016-2021e) & (K Pcs)
Table 37. North America Alectinib Sales by Type (2021-2026) & (K Pcs)
Table 38. North America Alectinib Sales by Application (2016-2021e) & (K Pcs)
Table 39. North America Alectinib Sales by Application (2021-2026) & (K Pcs)
Table 40. Europe Alectinib Sales by Country (2016-2021e) & (K Pcs)
Table 41. Europe Alectinib Sales by Country (2021-2026) & (K Pcs)
Table 42. Europe Alectinib Revenue by Country (2016-2021e) & (USD Million)
Table 43. Europe Alectinib Revenue by Country (2021-2026) & (USD Million)
Table 44. Europe Alectinib Sales by Type (2016-2021e) & (K Pcs)
Table 45. Europe Alectinib Sales by Type (2021-2026) & (K Pcs)
Table 46. Europe Alectinib Sales by Application (2016-2021e) & (K Pcs)
Table 47. Europe Alectinib Sales by Application (2021-2026) & (K Pcs)
Table 48. Asia-Pacific Alectinib Sales by Region (2016-2021e) & (K Pcs)
Table 49. Asia-Pacific Alectinib Sales by Region (2021-2026) & (K Pcs)
Table 50. Asia-Pacific Alectinib Revenue by Region (2016-2021e) & (USD Million)
Table 51. Asia-Pacific Alectinib Revenue by Region (2021-2026) & (USD Million)
Table 52. Asia-Pacific Alectinib Sales by Type (2016-2021e) & (K Pcs)
Table 53. Asia-Pacific Alectinib Sales by Type (2021-2026) & (K Pcs)
Table 54. Asia-Pacific Alectinib Sales by Application (2016-2021e) & (K Pcs)
Table 55. Asia-Pacific Alectinib Sales by Application (2021-2026) & (K Pcs)
Table 56. South America Alectinib Sales by Country (2016-2021e) & (K Pcs)
Table 57. South America Alectinib Sales by Country (2021-2026) & (K Pcs)
Table 58. South America Alectinib Revenue by Country (2016-2021e) & (USD Million)
Table 59. South America Alectinib Revenue by Country (2021-2026) & (USD Million)
Table 60. South America Alectinib Sales by Type (2016-2021e) & (K Pcs)
Table 61. South America Alectinib Sales by Type (2021-2026) & (K Pcs)
Table 62. South America Alectinib Sales by Application (2016-2021e) & (K Pcs)
Table 63. South America Alectinib Sales by Application (2021-2026) & (K Pcs)
Table 64. Middle East & Africa Alectinib Sales by Country (2016-2021e) & (K Pcs)
Table 65. Middle East & Africa Alectinib Sales by Country (2021-2026) & (K Pcs)
Table 66. Middle East & Africa Alectinib Revenue by Country (2016-2021e) & (USD Million)
Table 67. Middle East & Africa Alectinib Revenue by Country (2021-2026) & (USD Million)
Table 68. Middle East & Africa Alectinib Sales by Type (2016-2021e) & (K Pcs)
Table 69. Middle East & Africa Alectinib Sales by Type (2021-2026) & (K Pcs)
Table 70. Middle East & Africa Alectinib Sales by Application (2016-2021e) & (K Pcs)
Table 71. Middle East & Africa Alectinib Sales by Application (2021-2026) & (K Pcs)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Alectinib Typical Distributors
Table 75. Alectinib Typical Customers
List of Figures
Figure 1. Alectinib Picture
Figure 2. Global Alectinib Sales Market Share by Type in 2020
Figure 3. 150mg*140 Capsules
Figure 4. 150mg*28 Capsules
Figure 5. 20mg*1 Capsule
Figure 6. 40mg*1 Capsule
Figure 7. 150mg*26 Capsules
Figure 8. Global Alectinib Sales Market Share by Application in 2020
Figure 9. Unresectable NSCLC
Figure 10. Advanced NSCLC
Figure 11. Recurrent NSCLC
Figure 12. Other
Figure 13. Global Alectinib Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 14. Global Alectinib Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. United States Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Canada Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Mexico Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Germany Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. France Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. United Kingdom Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Russia Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Italy Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. China Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Japan Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Korea Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. India Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Southeast Asia Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Australia Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Brazil Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Egypt Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Saudi Arabia Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. South Africa Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Turkey Alectinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Global Alectinib Sales (2016-2026) & (K Pcs)
Figure 35. Global Alectinib Production Capacity (2016-2026) & (K Pcs)
Figure 36. Global Alectinib Production Capacity by Geographic Region: 2020 VS 2021
Figure 37. Alectinib Market Drivers
Figure 38. Alectinib Market Restraints
Figure 39. Alectinib Market Trends
Figure 40. Global Alectinib Sales Market Share by Manufacturer in 2020
Figure 41. Global Alectinib Revenue Market Share by Manufacturer in 2020
Figure 42. Alectinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 43. Top 3 Alectinib Manufacturer (Revenue) Market Share in 2020
Figure 44. Top 6 Alectinib Manufacturer (Revenue) Market Share in 2020
Figure 45. Global Alectinib Sales Market Share by Region (2016-2026)
Figure 46. Global Alectinib Revenue Market Share by Region (2016-2026)
Figure 47. North America Alectinib Revenue (2016-2026) & (USD Million)
Figure 48. Europe Alectinib Revenue (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Alectinib Revenue (2016-2026) & (USD Million)
Figure 50. South America Alectinib Revenue (2016-2026) & (USD Million)
Figure 51. Middle East & Africa Alectinib Revenue (2016-2026) & (USD Million)
Figure 52. Global Alectinib Sales Market Share by Type (2016-2026)
Figure 53. Global Alectinib Revenue Market Share by Type (2016-2026)
Figure 54. Global Alectinib Price by Type (2016-2026) & (USD/Pcs)
Figure 55. Global Alectinib Sales Market Share by Application (2016-2026)
Figure 56. Global Alectinib Revenue Market Share by Application (2016-2026)
Figure 57. Global Alectinib Price by Application (2016-2026) & (USD/Pcs)
Figure 58. North America Alectinib Sales Market Share by Country (2016-2026)
Figure 59. North America Alectinib Revenue Market Share by Country (2016-2026)
Figure 60. North America Alectinib Sales Market Share by Type (2016-2026)
Figure 61. North America Alectinib Sales Market Share by Application (2016-2026)
Figure 62. Europe Alectinib Sales Market Share by Country (2016-2026)
Figure 63. Europe Alectinib Revenue Market Share by Country (2016-2026)
Figure 64. Europe Alectinib Sales Market Share by Type (2016-2026)
Figure 65. Europe Alectinib Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Alectinib Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Alectinib Revenue Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Alectinib Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Alectinib Sales Market Share by Application (2016-2026)
Figure 70. South America Alectinib Sales Market Share by Country (2016-2026)
Figure 71. South America Alectinib Revenue Market Share by Country (2016-2026)
Figure 72. South America Alectinib Sales Market Share by Type (2016-2026)
Figure 73. South America Alectinib Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Alectinib Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Alectinib Revenue Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Alectinib Sales Market Share by Type (2016-2026)
Figure 77. Middle East & Africa Alectinib Sales Market Share by Application (2016-2026)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source